 |
|
Direct Comparison of the Relationship Between Clinical Outcome and Change in CD4+ Lymphocytes in Human Immunodeficiency Virus—Positive Homosexual Men and Injecting Drug Users
Joseph B. Margolick, MD, PhD;
Alvaro Muñoz, PhD;
David Vlahov, PhD;
Jacqueline Astemborski, MHS;
Liza Solomon, DrPH;
Xue-Ying He;
Kenrad E. Nelson, MD;
Alfred J. Saah, MD, MPH
Arch Intern Med. 1994;154(8):869-875.
Abstract
Background and Methods
To compare rates of decline of CD4+ lymphocytes among human immunodeficiency virus—positive homosexual men and injecting drug users, we followed up prevalent human immunodeficiency virus—positive homosexual men and current or former injecting drug users from February 1988 through August 1991. Subjects were free of acquired immunodeficiency syndrome at study entry and had semiannual clinical and laboratory evaluation, including measurement of T-cell subsets, under common protocols. Initial levels and rates of change of CD4+ lymphocyte counts were compared according to cohort membership and clinical progression, defined by the development of thrush or an acquired immunodeficiency syndrome—defining illness. Median follow-up was 30 months for both cohorts.
Results
At study entry, homosexual men had lower absolute numbers of circulating CD4+ lymphocytes than did injecting drug users (459/µL [0.46x109/L] vs 509/ µL, respectively). During follow-up, homosexual men exhibited a faster decline in CD4+ lymphocyte counts as well as more frequent development of HIV-related symptoms (thrush or acquired immunodeficiency syndrome). In both cohorts, initial levels of CD4+ lymphocytes and rates of decline in these cells were strongly associated with progression of disease, defined as remaining asymptomatic, onset of thrush, or onset of acquired immunodeficiency syndrome. Once homosexual men and injecting drug users were stratified by disease progression, their initial levels and rates of decline of CD4+ lymphocyte counts were similar. Thus, crude differences between the two study groups largely resulted from differences in development of clinical symptoms.
Conclusions
In these cohorts of homosexual men and injecting drug users, clinical outcome was much more important than risk group membership in determining changes in CD4+ lymphocyte numbers. The close similarity between the groups also suggests that drug use, ethnicity, and socioeconomic status play a minor role in the progression of human immunodeficiency virus infection.
(Arch Intern Med. 1994;154:869-875)
Author Affiliations
From the Departments of Environmental Health Sciences (Dr Margolick) and Epidemiology (Drs Muñoz, Vlahov, Solomon, Nelson, and Saah and Mss Astemborshi and He), The Johns Hopkins School of Hygiene and Public Health, Baltimore, Md.
 CiteULike  Connotea  Delicious  Digg  Facebook  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Optimizing Treatment Outcomes in HIV-Infected Patients with Substance Abuse Issues
Celentano and Lucas
Clinical Infectious Diseases 2007;45:S318-S323.
ABSTRACT
| FULL TEXT
Immune Status at Presentation to Care Did Not Improve among Antiretroviral-Naive Persons from 1990 to 2006
Keruly and Moore
Clinical Infectious Diseases 2007;45:1369-1374.
ABSTRACT
| FULL TEXT
The Role of Substance Abuse in HIV Disease Progression: Reconciling Differences from Laboratory and Epidemiologic Investigations
Kapadia et al.
Clinical Infectious Diseases 2005;41:1027-1034.
ABSTRACT
| FULL TEXT
Longitudinal Human Immunodeficiency Virus Type 1 Load in the Italian Seroconversion Study: Correlates and Temporal Trends of Virus Load
Lyles et al.
The Journal of Infectious Disease 1999;180:1018-1024.
ABSTRACT
| FULL TEXT
The Effect of Drug-Injection Behavior on Genetic Evolution of HIV-1
Carneiro et al.
The Journal of Infectious Disease 1999;180:1025-1032.
ABSTRACT
| FULL TEXT
High Rates of Transmission of Subtype E Human Immunodeficiency Virus Type 1 among Heterosexual Couples in Northern Thailand: Role of Sexually Transmitted Diseases and Immune Compromise
Nelson et al.
The Journal of Infectious Disease 1999;180:337-343.
ABSTRACT
| FULL TEXT
Category of exposure to HIV and age in the progression to AIDS: longitudinal study of 1199 people with known dates of seroconversion
Pezzotti et al.
BMJ 1996;313:583-586.
ABSTRACT
| FULL TEXT
|
